Nigeria’s medical community is mourning the death of public health physician and university administrator, Emeritus Professor Umaru Shehu.
Academic rigour, journalistic flair
Articles on Vaccination
Displaying 1 - 20 of 549 articles
Millions of high-risk older Australians aren’t getting recommended vaccinations against COVID, the flu, pneumococcal disease and shingles.
Currently we see more than 600,000 deaths from this mosquito-borne disease each year. This new vaccine – the second approved to treat malaria – could change things.
In this episode of The Conversation Weekly, we hear from the scientists behind a new malaria vaccine developed by the University of Oxford.
Chlamydia is devastating for koalas, but the vaccine to prevent infection requires a booster shot. Recapturing the animals for their booster shot is costly and stresses them, but there’s a solution.
No matter how much we believe our knowledge and our technological capabilities have evolved, pandemics prove we are still at the mercy of the natural world.
As COVID finds its equilibrium, infection rates will rise and fall, influenced by seasons, school holidays and new subvariants. Managing the risk is complex and needs to be cost effective.
Getting vaccinated is the best way to protect against diphtheria.
Seven children at a nursery in Stoke-on-Trent have caught measles. But other parts of the UK are at risk too.
Projections from the UKHSA suggest London could see a measles outbreak totalling 40,000 to 160,000 cases at current vaccination levels.
COVID-19 vaccination has been shown to be safe in pregnancy, and protects both the mother and infant from severe disease. It’s now also clear that infants’ antibody protection continues after birth.
The aim of vaccination is to prevent infection. In addition, vaccination is intended to reduce the risk of severe illness.
Widespread vaccination of children would likely avert thousands of cases of long COVID in the UK.
The only way an Alberta COVID-19 committee can meaningfully determine how public policy should be made is if it tackles head-on the question of how to measure the psychological impacts of policy.
Cases of the flu and COVID are set to rise over winter, with many people looking to get vaccinated against both viruses.
New analysis answers questions about the ongoing effectiveness of COVID vaccines: How well they protect against infection, hospitalization and death months after initial doses or after a booster shot.
While mRNA vaccines are designed to last longer in the body than mRNA molecules typically would, they are also tested to ensure they are eliminated from livestock long before milking or slaughter.
Three factors that can speed up adoption of clinical research discoveries are context, tailoring resources and efficient knowledge sharing.
As people flock back to offices and pack public transport, we’re seeing more cases of the flu than in recent years. The flu shot isn’t perfect but it cuts your chance of being hospitalised.
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
Job Board
-
Postdoctoral Research Fellow (Mathematical Modelling)
-
Casual Undergraduate/Postgraduate Teaching in Bachelor of Film, TV & Animation
-
Provost and Senior Vice-President, The Australian National University
-
Research Impact Analyst
-
Director, Portfolio Strategy and Operations
Top contributors
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Hon Prof, Dept of Child & Adolescent Health, University of Sydney
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor of Global Biosecurity, NHMRC Principal Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Honorary Research Fellow, Macquarie University
-
Associate professor, The University of Western Australia
-
Professorial Fellow, University of Canberra
-
Associate Principal Research Fellow, Burnet Institute
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Associate professor, UNSW Sydney
-
Professor of Infectious Diseases, Monash University
-
Professor in Applied Mathematics, University of Canterbury
-
Professor of Law, Boston University
